Regenerative therapies for equine degenerative joint disease: a preliminary study.
Degenerative joint disease (DJD) is a major cause of reduced athletic function and retirement in equine performers. For this reason, regenerative therapies for DJD have gained increasing interest. Platelet-rich plasma (PRP) and mesenchymal stem cells (MSCs) were isolated from a 6-year-old donor hors...
Main Authors: | Sarah Broeckx, Marieke Zimmerman, Sara Crocetti, Marc Suls, Tom Mariën, Stephen J Ferguson, Koen Chiers, Luc Duchateau, Alfredo Franco-Obregón, Karin Wuertz, Jan H Spaas |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3896436?pdf=render |
Similar Items
-
Chondrogenic Priming at Reduced Cell Density Enhances Cartilage Adhesion of Equine Allogeneic MSCs - a Loading Sensitive Phenomenon in an Organ Culture Study with 180 Explants
by: Jan H. Spaas, et al.
Published: (2015-09-01) -
Regenerative Skin Wound Healing in Mammals: State-of-the-Art on Growth Factor and Stem Cell Based Treatments
by: Bizunesh M. Borena, et al.
Published: (2015-04-01) -
Sphere-Forming Capacity as an Enrichment Strategy for Epithelial-Like Stem Cells from Equine Skin
by: Bizunesh M. Borena, et al.
Published: (2014-09-01) -
Assessing the functional properties of tenogenic primed mesenchymal stem cells in ex vivo equine tendon and ligament explants: A preliminary study
by: Eva Depuydt, et al.
Published: (2022-12-01) -
Tenogenically Induced Allogeneic Peripheral Blood Mesenchymal Stem Cells in Allogeneic Platelet-Rich Plasma: 2-Year Follow-up after Tendon or Ligament Treatment in Horses
by: Charlotte Beerts, et al.
Published: (2017-09-01)